Relmada Therapeutics, Inc. · NASDAQ:RLMD

Squadron Capital Management LLC reported a 6.20% stake in Relmada Therapeutics, Inc. (Schedule 13G)

Event Apr 24, 2025 · Filed May 1, 2025

Squadron Capital Management LLC reported a 6.20% stake in Relmada Therapeutics, Inc., 2,050,000 shares, as a passive investor on Apr 24, 2025. Filed May 1, 2025 (Schedule 13G).

Stake
6.20%
Shares
2,050,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP5.50%1,821,835
Squadron Capital Management LLC6.20%2,050,000
William Blank6.20%2,050,000

Source

View original at SEC

Related